ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Synthetic Biology Market – Global Industry Analysis, Size, Growth, Trends, and Forecast 2017 – 2025 – Healthcare Trends

DailyCommerceNewsSynthetic Biology Market – Global Industry Analysis, Size, Growth, Trends, and Forecast 2017 – 2025Healthcare TrendsIn-Depth research analysis of the Research industry. Research on the different Market size, Trends and the emerging for… Continue reading

2018-03-06 Michael Zand NEWS

New stem cell found in lung may offer target for regenerative medicine – The Philadelphia Tribune

Continue reading

2018-03-06 Michael Zand NEWS

Synthetic Biology Breakthrough Means Bacteria Could Produce Our Essential Drugs – Technology Networks

New stem cell found in lung may offer target for regenerative medicine
The Philadelphia Tribune
Newly identified stem cells in the lung that multiply rapidly after a pulmonary injury may offer an opportunity for innovative future treatments that harness the body’s ability to regenerate. Writing in the journal Nature, scientists describe cells …

Continue reading

2018-03-06 Michael Zand NEWS

Tiny UK Biotech Takes On Glaxo’s $730000 Gene Therapy – Bloomberg


Technology Networks

Synthetic Biology Breakthrough Means Bacteria Could Produce Our Essential Drugs
Technology Networks
Declan Bates, Professor of Bioengineering at the University of Warwick’s School of Engineering and Co-Director, Warwick Integrative Synthetic Biology Centre (WISB) commented “Synthetic Biology is about making cells easier to engineer so that we can …

and more »

Continue reading

2018-03-06 Michael Zand NEWS

Tiny UK Biotech Takes On Glaxo’s $730000 Gene Therapy – Bloomberg


Bloomberg

Tiny UK Biotech Takes On Glaxo’s $730000 Gene Therapy
Bloomberg
Glaxo was hailed as a pioneer for its work to develop Strimvelis, just the second gene therapy for an inherited disease to gain approval. Now CEO Emma Walmsley is pruning likely duds from the company’s pipeline of drugs and is seeking a partner for its …
Tiny Biotech Takes on Goliath Glaxo’s $730000 Gene TherapyBloombergQuint

all 1 news articles »

Continue reading

2018-03-06 Michael Zand NEWS

Researchers develop gene therapy that treats a form of macular degeneration in canine model – News-Medical.net

News-Medical.netResearchers develop gene therapy that treats a form of macular degeneration in canine modelNews-Medical.netResearchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degenera… Continue reading

2018-03-06 Michael Zand NEWS

Drug-producing bacteria possible with synthetic biology breakthrough – Infosurhoy


Bloomberg

Tiny UK Biotech Takes On Glaxo’s $730000 Gene Therapy
Bloomberg
Glaxo was hailed as a pioneer for its work to develop Strimvelis, just the second gene therapy for an inherited disease to gain approval. Now CEO Emma Walmsley is pruning likely duds from the company’s pipeline of drugs and is seeking a partner for its …
Tiny Biotech Takes on Goliath Glaxo’s $730000 Gene TherapyBloombergQuint

all 1 news articles »

Continue reading

2018-03-06 Michael Zand NEWS

Stem cell centers on the rise, claim high efficacy for treatment of knee osteoarthritis despite lack of evidence – PR Newswire (press release)

Stem cell centers on the rise, claim high efficacy for treatment of knee osteoarthritis despite lack of evidencePR Newswire (press release)NEW ORLEANS, March 6, 2018 /PRNewswire-USNewswire/ — Even with a lack of peer-reviewed evidence, the number of c… Continue reading

2018-03-06 Michael Zand NEWS
  • 1
  • …
  • 438
  • 439
  • 440
  • 441
  • 442
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Infosurhoy

Drug-producing bacteria possible with synthetic biology breakthrough
Infosurhoy
Led by the Warwick Integrative Synthetic Biology Centre at Warwick’s School of Engineering and the Faculty of Health and Medical Sciences at the University of Surrey, new research has discovered how to dynamically manage the allocation of essential …

and more »